TULA-2 (T-Cell Ubiquitin Ligand-2) Inhibits the Platelet Fc Receptor for IgG IIA (FcγRIIA) Signaling Pathway and Heparin-Induced Thrombocytopenia in Mice.

Arterioscler Thromb Vasc Biol

From the Department of Medicine, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA (Y.Z., S.A., S.R., L.C.E., P.F.B., S.E.M.); and Department of Physiology, Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, PA (C.A.D., A.Y.T., S.P.K.).

Published: December 2016

Objective: The objective of this study is to investigate the role of T-cell ubiquitin ligand-2 (TULA-2) in the platelet Fc receptor for IgG IIA (FcγRIIA) pathway and in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Approach And Results: HIT is a life-threatening thrombotic disease in which IgG antibodies against the heparin-platelet factor 4 complex activate platelets via FcγRIIA. We reported previously differential expression of TULA-2 in human population was linked to FcγRIIA responsiveness. In this study, we investigated the role of TULA-2, a protein phosphatase, in the FcγRIIA pathway and HIT pathogenesis by crossing TULA-2 mice with transgenic FcγRIIA mice. Ablation of TULA-2 resulted in hyperphosphorylation of spleen tyrosine kinase, linker for the activation of T cells, and phospholipase Cγ2 in platelets via FcγRIIA activation. Platelet integrin activation, granule secretion, phosphatidylserine exposure, and aggregation were also enhanced in TULA-2 murine platelets. Compared with wild-type mice, TULA-2 mice showed aggravated antibody-mediated thrombocytopenia, augmented thrombin generation, and shortened tail bleeding time. In contrast, there was no significant difference between TULA-2 and TULA-2 platelets in platelet spreading and clot retraction. Of note, heterozygous TULA-2 mice, whose platelets contained 50% as much protein as the TULA-2 platelets, showed significantly increased platelet reactivity and more severe thrombocytopenia in vivo compared with TULA-2 mice.

Conclusions: Together, the data demonstrate that not only the absence of TULA-2 but also the relative level of TULA-2 expression modulates FcγRIIA-mediated platelet reactivity and HIT in vivo. TULA-2 expression could be a valuable marker for HIT and inhibiting TULA-2 may serve as a potential therapy to reverse the bleeding adverse effect of anticoagulants.

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.116.307979DOI Listing

Publication Analysis

Top Keywords

tula-2
17
tula-2 mice
12
t-cell ubiquitin
8
ubiquitin ligand-2
8
platelet receptor
8
receptor igg
8
igg iia
8
iia fcγriia
8
heparin-induced thrombocytopenia
8
fcγriia pathway
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!